RPRX
Price:
$25.23
Market Cap:
$11.21B
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematol...[Read more]
Industry
Biotechnology
IPO Date
2020-06-16
Stock Exchange
NASDAQ
Ticker
RPRX
According to Royalty Pharma plc’s latest financial reports and current stock price. The company's current Current Ratio is 1.54. This represents a change of -80.37% compared to the average of 7.83 of the last 4 quarters.
The mean historical Current Ratio of Royalty Pharma plc over the last ten years is 7.79. The current 1.54 Current Ratio has changed 1.87% with respect to the historical average. Over the past ten years (40 quarters), RPRX's Current Ratio was at its highest in in the March 2022 quarter at 21.95. The Current Ratio was at its lowest in in the March 2019 quarter at 0.
Average
7.79
Median
7.90
Minimum
2.19
Maximum
16.81
Discovering the peaks and valleys of Royalty Pharma plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 260.59%
Maximum Annual Current Ratio = 16.81
Minimum Annual Increase = -86.97%
Minimum Annual Current Ratio = 2.19
Year | Current Ratio | Change |
---|---|---|
2023 | 7.90 | 260.59% |
2022 | 2.19 | -86.97% |
2021 | 16.81 | 91.88% |
2020 | 8.76 | 250.99% |
2019 | 2.50 | -44.50% |
2018 | 4.50 | -41.52% |
2017 | 7.69 | -23.91% |
2016 | 10.10 | 4.36% |
The current Current Ratio of Royalty Pharma plc (RPRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.96
5-year avg
7.63
10-year avg
7.79
Royalty Pharma plc’s Current Ratio is less than Prime Medicine, Inc. (6.50), less than Reneo Pharmaceuticals, Inc. (57.86), less than Ginkgo Bioworks Holdings, Inc. (5.79), greater than Ocean Biomedical, Inc. (0.04), less than Adaptive Biotechnologies Corporation (3.52), less than VectivBio Holding AG (9.14), less than Kinnate Biopharma Inc. (13.19), less than Ikena Oncology, Inc. (15.32), greater than Ascendis Pharma A/S (1.16), less than Apellis Pharmaceuticals, Inc. (4.36), less than BeiGene, Ltd. (1.93), less than Akero Therapeutics, Inc. (17.25), less than Blueprint Medicines Corporation (3.32), less than Iovance Biotherapeutics, Inc. (4.22), less than CureVac N.V. (6.20), less than Madrigal Pharmaceuticals, Inc. (5.98), less than Mirati Therapeutics, Inc. (7.54), less than IVERIC bio, Inc. (18.63), less than Amylyx Pharmaceuticals, Inc. (4.55), less than Karuna Therapeutics, Inc. (19.31), less than Day One Biopharmaceuticals, Inc. (14.62),
Company | Current Ratio | Market cap |
---|---|---|
6.50 | $362.00M | |
57.86 | $60.84M | |
5.79 | $538.58M | |
0.04 | $20.54M | |
3.52 | $943.03M | |
9.14 | $1.06B | |
13.19 | $124.99M | |
15.32 | $73.83M | |
1.16 | $8.29B | |
4.36 | $4.14B | |
1.93 | $20.06B | |
17.25 | $1.99B | |
3.32 | $5.75B | |
4.22 | $2.28B | |
6.20 | $670.67M | |
5.98 | $6.80B | |
7.54 | $4.12B | |
18.63 | $5.51B | |
4.55 | $274.19M | |
19.31 | $12.60B | |
14.62 | $1.28B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Royalty Pharma plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Royalty Pharma plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Royalty Pharma plc's Current Ratio?
How is the Current Ratio calculated for Royalty Pharma plc (RPRX)?
What is the highest Current Ratio for Royalty Pharma plc (RPRX)?
What is the 3-year average Current Ratio for Royalty Pharma plc (RPRX)?
What is the 5-year average Current Ratio for Royalty Pharma plc (RPRX)?
How does the current Current Ratio for Royalty Pharma plc (RPRX) compare to its historical average?